Get started
Author

Sreekanth Dittakavi

Observed name: Dittakavi, Sreekanth
ORCID: 0000-0002-5638-327X
Observed ORCID: 0000-0002-5638-327X
OpenAlex ID: A5061261022
High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide N -Methyltransferase (NNMT)
2019 · Rocco L. Policarpo, Ludovic Decultot, et al. · Journal of Medicinal Chemistry · 56
Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
2022 · Sven Ruf, Sridharan Rajagopal, et al. · Scientific Reports · 30
PDF
Validated HPLC‐MS/MS method for quantitation of AMG 510, a KRAS G12C inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice
2020 · Naveena Madhyastha, Swapan Kumar Samantha, et al. · Biomedical Chromatography · 21
Bioanalytical method development and validation for establishing bioavailability and bioequivalence
2021 · Suryanarayana Polaka, K Laxmi Swetha, et al. · Elsevier eBooks · 20
Quantitative analysis of enasidenib in dried blood spots of mouse blood using an increased‐sensitivity LC–MS/MS method: Application to a pharmacokinetic study
2019 · Sreekanth Dittakavi, Rakesh Kumar Jat, et al. · Biomedical Chromatography · 17
LC–MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic study
2017 · Sreekanth Dittakavi, Pavan Kumar V.S.P. Nagasuri, et al. · Journal of Pharmaceutical and Biomedical Analysis · 16
Validated HPLC‐UV method for simultaneous quantification of phosphatidylinositol 3‐kinase inhibitors, copanlisib, duvelisib and idelalisib, in rat plasma: Application to a pharmacokinetic study in rats
2020 · Anup Siddesh, Dhurvu Sriram, et al. · Biomedical Chromatography · 14
DBS Assay with LC-MS/MS for the Determination of Idelalisib, A Selective PI3K-δ Inhibitor in Mice Blood and Its Application to a Pharmacokinetic Study
2020 · Harsha K. Tripathy, Nair S.V. Manju, et al. · Drug Research · 10
Validated LC-MS/MS Method for Simultaneous Quantitation of Three PI3K Inhibitors, Copanlisib, Duvelisib and Idelalisib in Mouse Plasma: Application to a Pharmacokinetic Study in Mice
2021 · Bhavesh Babulal Gabani, Sreekanth Dittakavi, et al. · Analytical Chemistry Letters · 8
PDF
Validated HPLC method for simultaneous quantification of mutant IDH1/2 inhibitors (enasidenib, ivosidenib and vorasidenib) in mouse plasma: Application to a pharmacokinetic study
2019 · Ashok Zakkula, Sreekanth Dittakavi, et al. · Biomedical Chromatography · 8
High-Affinity Alkynyl Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT)
2019 · Rocco Policarpo, Ludovic Decultot, et al. · ChemRxiv · 7
A dried blood spot assay with HPLC–MS/MS for the determination of larotrectinib in mouse blood and its application to a pharmacokinetic study
2020 · Harsha K. Tripathy, Nair S.V. Manju, et al. · Biomedical Chromatography · 6
Validated HPLC Method for Quantification of a Novel Trk Inhibitor, Larotrectinib in Mice Plasma: Application to a Pharmacokinetic Study
2020 · Harsha K. Tripathy, S.V. Nair Manju, et al. · Drug Research · 6
Quantitation of Ivosidenib, A Novel Mutant IDH1 Inhibitoron Mice DBS: Application to a Pharmacokinetic Study
2019 · Sreekanth Dittakavi, Rakesh Kumar Jat, et al. · Drug Research · 6
Validated HPLC method for quantification of copanlisib in mice plasma: application to a pharmacokinetic study
2020 · Ashok Zakkula, Pavan Kumar Kurakula, et al. · ADMET & DMPK · 5
PDF
Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroxime
2019 · Ravi Kumar Jairam, Sadanand R. Mallurwar, et al. · Xenobiotica · 5
Validated LC-ESI-MS/MS method for the determination of ivosidenib in 10 µL mice plasma: application to a pharmacokinetic study
2019 · Sreekanth Dittakavi, Rakesh Kumar Jat, et al. · ADMET & DMPK · 5
PDF
LC–ESI–MS/MS determination of copanlisib, a novel PI3K inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice
2018 · Sreekanth Dittakavi, Ramesh Mullangi · Biomedical Chromatography · 5
Validated LC-MS/MS method for a third-generation BCr-Abl 1 inhibitor, vodobatinib quantification in rat plasma and brain tissue, and its application to preclinical pharmacokinetics
2025 · Keerthana Madipelli, Niranjan Veerla, et al. · Analytical Chemistry Letters · 4
Validated HPLC‐UV Method for the Quantification of a Novel BCr‐Abl 1 Inhibitor, Vodobatinib, in Rat Plasma: Application to a Pharmacokinetic Study
2025 · Sandeep Kaddare, Ashok Zakkula, et al. · Biomedical Chromatography · 4
Validated HPLC‐UV method for quantification of paxalisib, a pan PI3K and mTOR inhibitor in mouse plasma: Application to a pharmacokinetic study in mice
2023 · Ashok Zakkula, Harsha K. Tripathy, et al. · Biomedical Chromatography · 4
PDF
Development and Validation of an HPLC Method for Quantification of Filgotinib, a Novel JAK-1 Inhibitor in Mice Plasma: Application to a Pharmacokinetic Study
2020 · Ashok Zakkula, Shobha Pulipati, et al. · Drug Research · 4
PDF
High‐throughput screening assay for the quantification of Cer d18:1/16:0, d18:1/24:0, d18:1/24:1, d18:1/18:0, d18:1/14:0, d18:1/20:0, and d18:1/22:0 in HepG2 cells using RapidFire mass spectrometry
2019 · Sreekanth Dittakavi, Lavanya Mahadevan, et al. · Biomedical Chromatography · 4
Highly Sensitive LC–MS/MS Method for Determination of Dexamethasone in Rat Plasma and Brain Tissue: An Application to Pharmacokinetic Study in Rats
2024 · Rama Murthi Bestha, Ashok Zakkula, et al. · Biomedical Chromatography · 2
Validated LC–MS/MS method for the determination of copanlisib in mouse dried blood spots
2022 · Harsha K. Tripathy, Vinay Kiran, et al. · Biomedical Chromatography · 2
Works count: 38
Citation count: 274
H-index: 8
I10-index: 8
Year
Topic
Type